Suppr超能文献

肝地塞米松结合蛋白的异质性与特性

Heterogeneity and properties of hepatic dexamethasone-binding proteins.

作者信息

Liu S L, Webb T E

出版信息

Biochem J. 1979 Apr 15;180(1):187-93. doi: 10.1042/bj1800187.

Abstract

Evidence from experiments in vivo and in vitro is presented for the presence of three species of dexamethasone-binding proteins in rat liver, which are identified by chromatography on Sepharose 6B or by isoelectric focusing. Although two of these species (DI and DII) possess properties characteristic of a true receptor, the third binding protein (i.e. DIII), which migrates most slowly on Sepharose 6B, but has stability properties similar to protein DII, exhibits a 3-fold lower affinity for dexamethasone and the activated complex neither binds to DNA-cellulose nor translocates to the nucleus. Only the predominant liver receptor (DI), which is eluted first from Sepharose 6B, is present in Novikoff-hepatoma cytosol, suggesting that the major and minor species are not interconverted through simple dissociation during their isolation. The binding activities of all three species in the liver cytosol increase approx. 2-fold in vivo after adrenalectomy and show a transient 2-fold fall in vivo after the administration of cortisol. These changes in vivo in protein DIII shows a marked lag compared with those in proteins DI and DII, which change in parallel. It is therefore proposed that rat liver cytosol contains two dexamethasone receptors and a dexamethasone-binding protein that may be derived from these receptors.

摘要

体内和体外实验证据表明,大鼠肝脏中存在三种地塞米松结合蛋白,可通过琼脂糖6B柱层析或等电聚焦法进行鉴定。尽管其中两种蛋白(DI和DII)具有真正受体的特性,但第三种结合蛋白(即DIII)在琼脂糖6B上迁移最慢,但其稳定性与蛋白DII相似,对 地塞米松的亲和力低3倍,且活化复合物既不与DNA纤维素结合也不转移至细胞核。诺维科夫肝癌细胞溶质中仅存在首先从琼脂糖6B上洗脱的主要肝脏受体(DI),这表明主要和次要蛋白在分离过程中不会通过简单解离相互转化。肝脏细胞溶质中所有三种蛋白的结合活性在肾上腺切除术后在体内增加约2倍,在给予皮质醇后在体内短暂下降2倍。与平行变化的蛋白DI和DII相比,蛋白DIII在体内的这些变化显示出明显的滞后。因此,有人提出大鼠肝脏细胞溶质含有两种地塞米松受体和一种可能源自这些受体的地塞米松结合蛋白。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验